Notably, the present case represents a rare instance in which SACST failed to localize the tumor, whereas GLP-1 receptor-targeted imaging successfully did so, supporting the potential utility of this modality even in SACST-negative cases. This evidence concerns the gene GLP1R and neoplasm.